TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,229,000 | -11.7% | 70,000 | -51.2% | 0.17% | -15.3% |
Q2 2021 | $1,392,000 | -35.0% | 143,496 | -28.1% | 0.20% | -53.0% |
Q1 2021 | $2,143,000 | -59.3% | 199,569 | +63.1% | 0.42% | -58.7% |
Q4 2020 | $5,265,000 | +352.7% | 122,375 | -57.5% | 1.01% | +108.9% |
Q1 2020 | $1,163,000 | +787.8% | 287,906 | +1936.5% | 0.48% | +6800.0% |
Q1 2016 | $131,000 | – | 14,137 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AWM Investment Company, Inc. | 701,138 | $4,067,000 | 0.67% |
Matrix Capital Management Company, LP | 2,288,560 | $13,274,000 | 0.33% |
NEA Management Company, LLC | 1,250,000 | $7,250,000 | 0.31% |
Stanley-Laman Group, Ltd. | 139,403 | $809,000 | 0.20% |
Cormorant Asset Management, LP | 500,000 | $2,900,000 | 0.19% |
Tekla Capital Management LLC | 468,399 | $2,717,000 | 0.10% |
Wealth Alliance Advisory Group, LLC | 21,800 | $126,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $1,007,000 | 0.03% |
Artal Group S.A. | 150,000 | $870,000 | 0.02% |
Baker Brothers Advisors | 505,262 | $2,931,000 | 0.02% |